Repair of Atrial Septal Defect With Eisenmenger Syndrome After Long-Term Sildenafil Therapy

Annals of Thoracic Surgery

Volumn 89, Issue 5, 2010, Pages 1629-1630

  Kim, Young Hwue ^a   Yu, Jeong Jin ^a   Yun, Tae Jin ^a   Lee, Yonghee ^a   Kim, Yong Beom ^a   Choi, Hyung Soon ^a   Jhang, Won Kyoung ^a   Shin, Hong Ju ^a   Park, Jeong Jun ^a   Seo, Dong Man ^a   Ko, Jae Kon ^a   Park, In Sook ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN; SILDENAFIL; PIPERAZINE DERIVATIVE; PURINE DERIVATIVE; SULFONE; VASODILATOR AGENT;

ADULT; ARTERY DISEASE; ARTICLE; BALLOON OCCLUSION; BLOOD VESSEL REACTIVITY; BODY SURFACE; CASE REPORT; CONSERVATIVE TREATMENT; CYANOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; DYSPNEA; ECHOCARDIOGRAPHY; EISENMENGER COMPLEX; FEMALE; FOLLOW UP; HEART ATRIUM SEPTUM DEFECT; HEART CATHETERIZATION; HEART INDEX; HEART RIGHT ATRIUM PRESSURE; HUMAN; HUMAN TISSUE; LONG TERM CARE; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; OPEN LUNG BIOPSY; OXYGEN SATURATION; PATIENT MONITORING; PRESCRIPTION; PRIORITY JOURNAL; REDUCTION; SYSTEMIC VASCULAR RESISTANCE; TREATMENT DURATION; TRICUSPID VALVE REGURGITATION; WALKING; COMPUTER ASSISTED TOMOGRAPHY; DOPPLER ECHOCARDIOGRAPHY; HEART SEPTUM DEFECT; HEART SURGERY; HOSPITALIZATION; METHODOLOGY; PULMONARY HYPERTENSION; RISK ASSESSMENT; TIME; TREATMENT OUTCOME;

ADULT; CARDIAC SURGICAL PROCEDURES; ECHOCARDIOGRAPHY, DOPPLER, COLOR; EISENMENGER COMPLEX; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; HYPERTENSION, PULMONARY; LONG-TERM CARE; PIPERAZINES; PURINES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SULFONES; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 77953030156     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2009.10.027     Document Type: Article

References (6)

1. Dimopoulos K., Peset A., and Gatzoulis M.A. Evaluating operability in adults with congenital heart disease and the role of pretreatment with targeted pulmonary arterial hypertension therapy. Int J Cardiol 129 (2008) 163-171
2. Frost A.E., Quinones M.A., Zoghbi W.A., and Noon G.P. Reversal of pulmonary hypertension and subsequent repair of atrial septal defect after treatment with continuous intravenous epoprostenol. J Heart Lung Transplant 24 (2005) 501-503
3. Schwerzmann M., Zafar M., McLaughlin P.R., Chamberlain D.W., Webb G., and Granton J. Atrial septal defect closure in a patient with 'irreversible' pulmonary hypertensive arteriopathy. Int J Cardiol 110 (2006) 104-107
4. Hoetzenecker K., Ankersmit H.J., Bonderman D., et al. Atrial septal defect repair after a 10-month treatment with bosentan in a patient with severe pulmonary arterial hypertension: A case report. J Thorac Cardiovasc Surg 137 (2009) 760-761
5. Balzer D.T., Kort H.W., Day R.W., et al. Inhaled nitric oxide as a preoperative test (INOP Test I): The INOP test study group. Circulation 106 (2002) I-76-I-81
6. Steele P.M., Fuster V., Cohen M., Ritter D.G., and McGoon D.C. Isolated atrial septal defect with pulmonary vascular obstructive disease-long-term follow-up and prediction of outcome after surgical correction. Circulation 76 (1987) 1037-1042